Dynasty Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,303
Closed -$372K 370
2025
Q4
$372K Sell
7,303
-584
-7% -$29.9K ﹤0.01% 265
2025
Q3
$438K Buy
+7,887
New +$462K 0.01% 234
2025
Q1
Sell
-10,546
Closed -$907K 262
2024
Q4
$907K Sell
10,546
-1,214
-10% -$131K 0.02% 154
2024
Q3
$1.4M Sell
11,760
-490
-4% -$65.3K 0.04% 102
2024
Q2
$1.75M Buy
12,250
+1,010
+9% +$134K 0.05% 86
2024
Q1
$1.44M Buy
+11,240
New +$1.34M 0.05% 91

Other funds holding NVO

Dynasty Wealth Management's NVO Position: Q1 2026 in Review

Dynasty Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 7,303 shares — an estimated $372K sold.

Dynasty Wealth Management first reported a position in NVO in Q1 2024 and held it in 6 quarters. The position peaked at $1.75M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Dynasty Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Dynasty Wealth Management sold 7,303 Novo Nordisk shares in Q1 2026, an estimated $372K.
  • Dynasty Wealth Management first reported a position in Novo Nordisk in Q1 2024 and held it in 6 quarters.
  • Dynasty Wealth Management's Novo Nordisk position peaked at $1.75M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Dynasty Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.